Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes by Yu Su, Shuo Zhang, Shuo Zhang, Shuo Zhang, Zezhen Wu, Zezhen Wu, Zezhen Wu, Weiting Liu, Jingxian Chen, Jingxian Chen, Feiying Deng, Feiying Deng, Feiying Deng, Fengwu Chen, Fengwu Chen, Dan Zhu, Kaijian Hou

Get full text

Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes: A systematic review by Shuo Zhang, Shuo Zhang, Feiying Deng, Feiying Deng, Jingxian Chen, Jingxian Chen, Fengwu Chen, Fengwu Chen, Zezhen Wu, Zezhen Wu, Liping Li, Kaijian Hou, Kaijian Hou

Get full text

Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial by Shuo Zhang, Shuo Zhang, Shuo Zhang, Chuanyan Zhang, Chuanyan Zhang, Jingxian Chen, Jingxian Chen, Feiying Deng, Feiying Deng, Zezhen Wu, Zezhen Wu, Dan Zhu, Fengwu Chen, Yale Duan, Yue Zhao, Kaijian Hou, Kaijian Hou, Kaijian Hou

Get full text

Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on “time in range” in patients with type 2 diabetes by Yongru Chen, Jingxian Chen, Jingxian Chen, Shuo Zhang, Shuo Zhang, Dan Zhu, Feiying Deng, Feiying Deng, Rui Zuo, Yufei Hu, Yue Zhao, Yale Duan, Benwei Lin, Fengwu Chen, Yun Liang, Jiaxiong Zheng, Barkat Ali Khan, Kaijian Hou

Get full text

Relationship between gut microbiota and the pathogenesis of gestational diabetes mellitus: a systematic review by Sheng Ma, Yuping Wang, Xiaoxia Ji, Sunjuan Dong, Shengnan Wang, Shuo Zhang, Feiying Deng, Jingxian Chen, Benwei Lin, Barkat Ali Khan, Weiting Liu, Kaijian Hou, Kaijian Hou

Get full text